Article
Proximity labeling reveals unique and shared interactomes of unmodified and pyroglutamate amyloid beta in human hippocampus in Alzheimer’s disease
2026-05-19
Abstract excerpt
<title>Abstract</title> <p>Amyloid plaques are a hallmark neuropathological feature of Alzheimer's disease (AD), composed of insoluble amyloid beta (Aβ) peptide. Aβ undergoes post-translational modifications that alter their biophysical properties, aggregation kinetics, and neurotoxicity, creating a heterogeneous pool of species that differentially affect AD pathogenesis. Pyroglutamate-modified Aβ (pEAβ) is a par...
Topics
Open a Topic to create a Post that cites this publication.
- Advanced Proteomics Techniques and Applications
- Alzheimer's disease research and treatments
- Biotin and Related Studies
- Cholinesterase and Neurodegenerative Diseases
- Genetic Neurodegenerative Diseases
- Parkinson's Disease Mechanisms and Treatments
- Protein Hydrolysis and Bioactive Peptides
- S100 Proteins and Annexins
Identifiers and source
- Literature Corpus work
- f756af9c-9cec-5cbd-baef-54497d74f95a
- DOI
- 10.21203/rs.3.rs-9620660/v1
